MD Magazine’s Kevin Kunzmann reports on Joseph Han, MD and the SINUS-24 Trial results. Han revealed monoclonal antibody biologic dupilumab (Dupixnt) may positively impact chronic rhinosinusitis patients with nasal polyps.  The SINUS-24 trial was a multicenter,...